Screen for SCID and SMA

The adoption of newborn screening programs for SCID (severe combined immunodeficiency) and SMA (spinal muscular atrophy) are rapidly gaining momentum worldwide.

However, the integration and inclusion of new screening solutions into incredibly busy and crowded newborn screening labs often presents significant challenges.

This is why Revvity designed the Eonis Q workflow and system - to make SMA and SCID screening now a reality for labs of all sizes.

How we've simplified the Eonis Q dry chemistry workflow

• Reagents are dried on the plate: no need for a master mix preparation
• Multiplex from a single dried blood spot punch
• Quantification without calibrators
• Analyze over 500 samples per day

The Eonis Q is designed to be compact, offering a streamlined workflow with a swift 3-hour turnaround, eliminating wash steps and reducing the need for extensive pipetting and centrifuging processes. 

Uniquely customized for newborn screening laboratories

• Easy to use without any previous experience of qPCR software
• The same software is used for managing the PCR run and analyzing the result

Seamless integration

• Connects to LIMS system easily with no extra tools needed to run the analysis

Time to report

• Fast reporting: no manual data handling, that requires extra time

Troubleshooting packages

•  With just one click, you can easily share files with our customer support if you need assistance

Quality control monitoring

• Built in QC monitoring ensures you can track your QC level over time: no need to keep any separate files for tracking